DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...
The total number of petitions for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB) has plummeted over ...
Scientists have created a silicon chip that can write dozens of DNA sequences simultaneously using electricity and ...
The U.S. Aptamers Market is projected to grow from USD 1.49 Billion in 2025 to USD 11.90 Billion by 2035, while Europe is ...
A 1,563‑sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.
The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.
To prevent viruses from sickening or killing us—whether it's an individual case of hepatitis B or a COVID pandemic—it's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results